LP21309-7

Didanosine

Active

Descriptions

A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite. Source: National Library of Medicine, MeSH 2006

Didanosine is a Nucleoside Reverse Transcriptase Inhibitor(NRTI) antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions. Source: Regenstrief Institute

Basic Part Properties

Part Name

Didanosine

Part Display Name

Didanosine

Part Type

Component (Describes the core component or analyte measured)

Created On

2001-01-02

Construct for LOINC Short Name

Didanosine

Related Codes

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.

CodeSystem lookup

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP21309-7

ConceptMap translate

https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP21309-7

Language Variants Get Info

LOINC Copyright

Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.